買瘋了，港股還可以買啥？
昨天港股大跳水，許多人擔憂會不會10月8日重演，我們指出了，當前環境與那時有三個不同，因此，港股不具備深跌的基礎。結果今天港股就大反包了，情人節大禮包，恆科暴漲5個點，再創新高。
相比港股的走勢如虹，A股的指數則在各種資金博弈中，走得很擰巴。就是，港股那邊，外資已經在瘋狂掃貨了，A股這邊內資各種資金還在互相博弈互相收割。
AI板塊出現了分歧，便依然是最強板塊，今天最牛的是AI+醫療，另外，前天輪了新能源，昨天輪了白酒，今天就輪了醫藥，除了AI+醫療，整個醫藥板塊今天都強。
嘉和美康、達安基因、塞力醫逆等漲停，衛寧健康大漲18個點，美年健康6天4板。CXO板塊今天也非常強，尤其是港股那邊，藥明H、泰格H、康龍H都是10個點的漲幅。
其他AI，像拓維信息，數據港等繼續漲停。但也有弱的，如之前很強的每日互動，今天就暴跌8個點，昨天拉了一個62.62的對子頂（溜啊溜啊）。視覺中國、美格智能跌停。總之就是，AI板塊出現了分歧，波動加劇，賺錢容易，虧錢也容易。
然後哪吒繼續封神，光線傳媒再次20CM封板，光線的市值也達到了1000億。
而昨天稍有表現的消費今天又萎靡不振了，A股的博弈走得就是這麼糾結。
港股那邊就沒有A股這樣的雞賊心里，外資相對直來直去，不看好就一個勁地賣，看好就瘋掃。相反是內資多少繼續有點雞賊，昨天下午預計就是內資砸的盤，結果晚上中概外資繼續賣，於是今天就反包了。
現在的投資人心理，但凡多看一眼盤，就會忍不住賣掉港股，但凡一賣，就飛了。那麼：
這波漲勢如虹的港股行情會持續到什麼時候？當前還有什麼港股可以上車？
說好的以消費爲代表的順週期博弈兩會行情還有沒有？
AI的分歧繼續，波動加大，應該如何應對？
都說A股醫藥漲是行情終結者，這次會不一樣嗎？
更專業詳細的市場機會分享，歡迎加入《格隆匯研究院羣英會》全天候直播：帶你釐清真相，識別潛在風險，抓準真機會。
掃碼加入《格隆匯研究院羣英會》
帶你釐清真相，識別風險，抓準真機會！
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
